in this issue
Regions :: North America
Bayer CropScience Completes Acquisition of U.S. Biotech Firm for $365 Million
8:07 AM MST | November 3, 2009 | Deepti Ramesh
Bayer CropScience says it has completed the previously announced acquisition of Athenix (Research Triangle Park, NC), a privately held biotechnology company, for $365 million. Further cash payments based on the achievement of certain development milestones may amount up to $35 million, Bayer CropScience says. The acquisition will complement Bayer CropScience's fast growing BioScience business by significantly extending its R&D presence in North America. It will also bolster Bayer CropScience's trait platform for established core crops such as oilseeds...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee